Hepatoprotective effects of late-stage clinical drug candidates and dietary intervention in the non-obese CDAA-HFD mouse model of advanced MASH with progressive fibrosis

Accession: GSE269493
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: drug/treatment response)
Modality / assay: drug-response
Platform: Expression profiling by high throughput sequencing, GPL21626
Organism: Mus musculus
Samples: 81
Size (indexed): 2.9 MB (3030077 bytes)
Downloaded bytes: 2.9 MB (3030077 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE269493_CDAA_intervention_counts.txt.gz1.5 MBa04a94096836dd72…
GSE269493_CDAA_progression_counts.txt.gz1.4 MB5528afc6b9fd150a…

Index note: 2 file(s); GSE269493_CDAA_intervention_counts

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T16:51:43Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL21626 dataset provides single-cell gene expression from mus musculus liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 81 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.